These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 25978433)
1. The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells. Lai YS; Chen JY; Tsai HJ; Chen TY; Hung WC Blood Cancer J; 2015 May; 5(5):e313. PubMed ID: 25978433 [TBL] [Abstract][Full Text] [Related]
2. Anti-leukemia activity of chaetocin via death receptor-dependent apoptosis and dual modulation of the histone methyl-transferase SUV39H1. Chaib H; Nebbioso A; Prebet T; Castellano R; Garbit S; Restouin A; Vey N; Altucci L; Collette Y Leukemia; 2012 Apr; 26(4):662-74. PubMed ID: 21979880 [TBL] [Abstract][Full Text] [Related]
3. Improved therapeutic effect against leukemia by a combination of the histone methyltransferase inhibitor chaetocin and the histone deacetylase inhibitor trichostatin A. Tran HT; Kim HN; Lee IK; Nguyen-Pham TN; Ahn JS; Kim YK; Lee JJ; Park KS; Kook H; Kim HJ J Korean Med Sci; 2013 Feb; 28(2):237-46. PubMed ID: 23400519 [TBL] [Abstract][Full Text] [Related]
4. The Suv39H1 methyltransferase inhibitor chaetocin causes induction of integrated HIV-1 without producing a T cell response. Bernhard W; Barreto K; Saunders A; Dahabieh MS; Johnson P; Sadowski I FEBS Lett; 2011 Nov; 585(22):3549-54. PubMed ID: 22020221 [TBL] [Abstract][Full Text] [Related]
5. Reexpression of epigenetically silenced AML tumor suppressor genes by SUV39H1 inhibition. Lakshmikuttyamma A; Scott SA; DeCoteau JF; Geyer CR Oncogene; 2010 Jan; 29(4):576-88. PubMed ID: 19881540 [TBL] [Abstract][Full Text] [Related]
6. Gfi-1 is the transcriptional repressor of SOCS1 in acute myeloid leukemia cells. Lee MC; Kuo YY; Chou WC; Hou HA; Hsiao M; Tien HF J Leukoc Biol; 2014 Jan; 95(1):105-15. PubMed ID: 24018353 [TBL] [Abstract][Full Text] [Related]
7. Histone lysine methyltransferase SUV39H1 is a potent target for epigenetic therapy of hepatocellular carcinoma. Chiba T; Saito T; Yuki K; Zen Y; Koide S; Kanogawa N; Motoyama T; Ogasawara S; Suzuki E; Ooka Y; Tawada A; Otsuka M; Miyazaki M; Iwama A; Yokosuka O Int J Cancer; 2015 Jan; 136(2):289-98. PubMed ID: 24844570 [TBL] [Abstract][Full Text] [Related]
8. Chaetocin-mediated SUV39H1 inhibition targets stemness and oncogenic networks of diffuse midline gliomas and synergizes with ONC201. Xin DE; Liao Y; Rao R; Ogurek S; Sengupta S; Xin M; Bayat AE; Seibel WL; Graham RT; Koschmann C; Lu QR Neuro Oncol; 2024 Apr; 26(4):735-748. PubMed ID: 38011799 [TBL] [Abstract][Full Text] [Related]
9. 5-azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation. Füller M; Klein M; Schmidt E; Rohde C; Göllner S; Schulze I; Qianli J; Berdel WE; Edemir B; Müller-Tidow C; Tschanter P Int J Oncol; 2015 Mar; 46(3):1192-204. PubMed ID: 25501798 [TBL] [Abstract][Full Text] [Related]
10. Aberrant histone methylation and the effect of Suv39H1 siRNA on gastric carcinoma. Cai L; Ma X; Huang Y; Zou Y; Chen X Oncol Rep; 2014 Jun; 31(6):2593-600. PubMed ID: 24737085 [TBL] [Abstract][Full Text] [Related]
11. Chaetocin induces endoplasmic reticulum stress response and leads to death receptor 5-dependent apoptosis in human non-small cell lung cancer cells. Liu X; Guo S; Liu X; Su L Apoptosis; 2015 Nov; 20(11):1499-507. PubMed ID: 26349783 [TBL] [Abstract][Full Text] [Related]
12. Effects of histone methyltransferase inhibitor chaetocin on histone H3K9 methylation of cultured ovine somatic cells and development of preimplantation cloned embryos. Zhang YM; Gao EE; Wang QQ; Tian H; Hou J Reprod Toxicol; 2018 Aug; 79():124-131. PubMed ID: 29909068 [TBL] [Abstract][Full Text] [Related]
13. Histone methyltransferase inhibitors induce HIV-1 recovery in resting CD4(+) T cells from HIV-1-infected HAART-treated patients. Bouchat S; Gatot JS; Kabeya K; Cardona C; Colin L; Herbein G; De Wit S; Clumeck N; Lambotte O; Rouzioux C; Rohr O; Van Lint C AIDS; 2012 Jul; 26(12):1473-82. PubMed ID: 22555163 [TBL] [Abstract][Full Text] [Related]
14. Chaetocin disrupts the SUV39H1-HP1 interaction independent of SUV39H1 methyltransferase activity. Han L; Lee JB; Indermaur EW; Keung AJ Biochem J; 2023 Mar; 480(6):421-432. PubMed ID: 36896918 [TBL] [Abstract][Full Text] [Related]
15. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts. Gozzini A; Santini V Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241 [TBL] [Abstract][Full Text] [Related]
16. High Glucose Increases the Expression of Inflammatory Cytokine Genes in Macrophages Through H3K9 Methyltransferase Mechanism. Li MF; Zhang R; Li TT; Chen MY; Li LX; Lu JX; Jia WP J Interferon Cytokine Res; 2016 Jan; 36(1):48-61. PubMed ID: 26406561 [TBL] [Abstract][Full Text] [Related]
17. SUV39H1 is a New Client Protein of Hsp90 Degradated by Chaetocin as a Novel C-Terminal Inhibitor of Hsp90. Lian B; Lin Q; Tang W; Qi X; Li J Biomol Ther (Seoul); 2021 Jan; 29(1):73-82. PubMed ID: 33162400 [TBL] [Abstract][Full Text] [Related]
18. A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a. Spensberger D; Delwel R FEBS Lett; 2008 Aug; 582(18):2761-7. PubMed ID: 18619962 [TBL] [Abstract][Full Text] [Related]
19. The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells. Trus MR; Yang L; Suarez Saiz F; Bordeleau L; Jurisica I; Minden MD Leukemia; 2005 Jul; 19(7):1161-8. PubMed ID: 15902297 [TBL] [Abstract][Full Text] [Related]